Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 20/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21590616 | 1.00 | GABRA1 (0.46) | GABRA1 | |
| SCHEMBL21593336 | 0.92 | GABRA1 (0.39) | GABRA1 | |
| SCHEMBL21590713 | 0.92 | GABRA1 (0.50) | GABRA1 | |
| SCHEMBL21590682 | 0.89 | GABRA1 (0.44) | GABRA1 | |
| SCHEMBL30694848 | 0.89 | GABRA1 (0.46) | GABRA1 | |
| SCHEMBL21590700 | 0.89 | GABRA1 (0.46) | GABRA1 | |
| SCHEMBL23169040 | 0.88 | GABRA1 (0.44) | GABRA1 | |
| SCHEMBL21590674 | 0.88 | GABRA1 (0.45) | GABRA1 | |
| SCHEMBL21590658 | 0.88 | GABRA1 (0.42) | GABRA1 | |
| SCHEMBL30694879 | 0.88 | GABRA1 (0.45) | GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11840528-B2 | Isoxazolyl ether derivatives as GABAA α5 PAM | HOFFMANN-LA ROCHE INC. (US) | 2023-12-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11840528-B2 | Isoxazolyl ether derivatives as GABAA α5 PAM | GABRA5, GABRA2, GABRB2 | GABRA1 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.